Karuna Therapeutics Investor Relations Material
Latest events
Q3 2023
Karuna Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Karuna Therapeutics Inc
Access all reports
Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurological and psychiatric disorders. The company's research focuses on discovering and utilizing novel pathways for medications that aim to significantly improve the lives of those affected by conditions such as schizophrenia and dementia-related psychosis. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
KRTX
Country
🇺🇸 United States